Due to counterfeiting, adulteration, theft and diversion, governments and regulatory agencies have developed regulations to enhance patient safety and supply chain security. On November 27, 2013, the Drug Supply Chain Security Act (DSCSA) made effective several additional requirements that impact labeling and data management for commercially distributed prescription human drug product in the US.
Alcami's new customer portal allows you unprecedented and rapid access and visualization into your ongoing projects. Now you can request a quote, submit your samples and check the test status of your materials online and on your mobile device.
Whether you are looking for an all-inclusive integrated offering or an individualized development or manufacturing service, Alcami has the solution to the complex needs of your product.
Our Virtual Lab experience connects you to Alcami, using innovative immersive reality technology. Discover our fully integrated outsourcing services from clinical to commercialization, providing the best outcome for your product on every level.
Elemental Impurities - Missed the Deadline? Now What?
Accelerating Drug Development through Automation
Abuse-Deterrent Category One Testing: Syringeability Studies
Panel Discussion: Oral Solid Dosage Manufacturing Process
Editorial: Driving Change in the Pharma Industry and Biotech One Relationship at a Time
Editorial: Is industry ready for the serialisation shake-up?
Editorial: Transparent and Timely Testing
Serialization CDMO Checklist
Editorial: Pharma CEO Talks Company Growth, Jobs with New Triangle HQ
Alcami Donation to Outfit TROSA Medical Department
Alcami Supports STEM Education at Local High School
April 17-19 - Interphex 2018April 18-20 - CPhI JapanApril 24-26 - CPhI North AmericaApril 25-27 - World Orphan Drug Congress 2018
